Novavax: Australia Cancels Delivery of Some COVID-19 Doses

December 18, 2024, 10:36 PM UTC

Novavax said Australia canceled certain doses of the company’s COVID-19 vaccine in an amendment to their 2020 advanced purchase agreement.

  • Will credit about $31m of advanced payment against outstanding invoices and invoices for the future delivery of about 3m doses
  • Doses were scheduled for delivery between the fourth quarter of 2023 and the fourth quarter of 2025
  • Also updated vaccine delivery schedule through 2029

To view the source of this information, click here

To contact the reporter on this story:
Allegra Fradkin in New York at afradkin@bloomberg.net

To contact the editor responsible for this story:
Zachary Fleming at zfleming2@bloomberg.net

© ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.